Author

Aerica Nagornyuk

University of North Dakota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Motoki TakakuiD· 2 shared Aussie SuzukiiD· 1 shared Deepak Balakrishnan PoduvaliD· 1 shared Hideyuki Yamada· 1 shared Jennifer G. DeLucaiD· 1 shared Mamoru TakadaiD· 1 shared Masayuki OhtsukaiD· 1 shared Mika SaotomeiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Motoki TakakuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyeLifePeer-reviewedMay 19, 2025

Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells

Yu‐Chia Chen, Mamoru Takada, Aerica Nagornyuk…·Aussie Suzuki

This study shows that inhibiting the p38-MK2 pathway enhances the effectiveness of microtubule inhibitors in breast cancer cells while sparing normal cells.

2 citations

humanexperimental assay

𝕏 PostBluesky

GenomicsNucleic Acids ResearchPeer-reviewedJan 28, 2024

Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4

Mika Saotome, Deepak Balakrishnan Poduval, Sara A. Grimm…·Motoki Takaku

This study shows CHD4 prevents inappropriate gene activation by editing transcription factor binding site selection through chromatin remodeling in breast cancer cells and during reprogramming.

15 citations

humanChIP-seq

𝕏 PostBluesky